THE EFFICACY, SIDE-EFFECTS, AND MORTALITY COMPARISON BETWEEN PARACETAMOL AND IBUPROFEN IN PATENT DUCTUS ARTERIOSUS TREATMENT FOR PREMATURE INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, have long been a standard pharmacotherapy for patent ductus arteriosus (PDA). However, recently, paracetamol has also proven to produce the same effect by preventing prostaglandin synthesis. Several studies have compared the efficacy a...
Guardado en:
Autor principal: | Lokot Donna Lubis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Associazione Italiana Giovani Medici
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5ac5cf6690364221b1fc0fb49ad3f9b0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anterior Minithoracotomy vs. Transcatheter Closure of Patent Ductus Arteriosus in Very Preterm Infants
por: Marien Lenoir, et al.
Publicado: (2021) -
Immediate angiographic residual shunt using the Nit-Occlud device for patent ductus arteriosus closure
por: Gurumurthy Hiremath, et al.
Publicado: (2020) -
Short‐term ventriculo‐arterial coupling and myocardial work efficiency in preterm infants undergoing percutaneous patent ductus arteriosus closure
por: Adrianne R. Bischoff, et al.
Publicado: (2021) -
Management of patients with patent ductus arteriosus: Challenges and outcome in low-resource settings
por: Ismail Inuwa Mohammed, et al.
Publicado: (2021) -
Duktus Arteriosus pada Bayi Prematur
por: Agus Cahyono
Publicado: (2020)